Earnings in 2d
ENLV · NASDAQ · Biotechnology

Enlivex

Develops Allocetra for knee osteoarthritis and manages a RAIN-centered digital-asset treasury.

$1.36
After-hours close−0.01 (−0.47%)
At close$1.37(−7.12%)
DateEstimateReportedSurprise
Aug 2026−$0.31
Mar 2026−$0.45−$3.45−666.7%
Mar 2026−$1.29$410.25+31,791.8%
Dec 2025−$1.80−$0.12+93.5%
Nov 2025−$0.12−$0.09+25.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Sep 2025
Aug 2025
Jun 2025
May 2025
Apr 2025
Feb 2025
Nov 2024
Nov 2024
Sep 2024
Aug 2024
Jun 2024
Jun 2024
Mar 2024
Dec 2023
Nov 2023
Sep 2023
Sep 2023
Jun 2023
Apr 2023
Mar 2023
Dec 2022
Aug 2022
May 2022
Apr 2022
Nov 2021
Aug 2021
Jun 2021
Apr 2021
Oct 2020
Aug 2020
May 2020
Apr 2020
Nov 2019
Jul 2019
May 2019
Apr 2019
Mar 2019
Dec 2018
Nov 2018
Jul 2018
Apr 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Aug 31, 2026−$0.31
Mar 30, 2026−$0.45−$3.45−666.7%
Mar 25, 2026−$1.29$410.25+31,791.8%
Dec 5, 2025−$1.80−$0.12+93.5%
Nov 14, 2025−$0.12−$0.09+25.0%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Sep 5, 2025
Aug 29, 2025
Jun 13, 2025
May 30, 2025
Apr 4, 2025
Feb 26, 2025
Nov 29, 2024
Nov 28, 2024
Sep 6, 2024
Aug 30, 2024
Jun 21, 2024
Jun 14, 2024
Mar 29, 2024
Dec 4, 2023
Nov 9, 2023
Sep 4, 2023
Sep 1, 2023
Jun 26, 2023
Apr 4, 2023
Mar 31, 2023
Dec 5, 2022
Aug 22, 2022
May 27, 2022
Apr 29, 2022
Nov 22, 2021
Aug 9, 2021
Jun 1, 2021
Apr 30, 2021
Oct 30, 2020
Aug 14, 2020
May 18, 2020
Apr 30, 2020
Nov 14, 2019
Jul 26, 2019
May 20, 2019
Apr 30, 2019
Mar 27, 2019
Dec 31, 2018
Nov 19, 2018
Jul 26, 2018
Apr 23, 2018